Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Davidson, Bruce L.Tapson, Victor F.
Irwin, Richard S.
French, Cynthia L.
Elliott, C. Gregory
Levi, Marcel
UMass Chan Affiliations
Graduate School of NursingDepartment of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine
Document Type
EditorialPublication Date
2020-12-15Keywords
pharyngeal antisepsisantiseptic mouthwash
washing the throat
COVID-19
pneumonia
Infectious Disease
Public Health
Pulmonology
Virus Diseases
Metadata
Show full item recordAbstract
Antiseptic mouthwash use to control coronavirus disease 2019 (COVID-19) has been proposed, disputed, and dismissed without understanding the proposal and without serious consideration of merits and counterarguments. Adding a proven, safe, and evidence-based clinically reasonable measure to existing approaches of universal masking and social distancing, while awaiting a safe and effective vaccine, seems a constructive approach worth implementing and observing for efficacy. We describe how adding pharyngeal antisepsis, “washing the throat,” before sleeping, when healthy adults of all ages aspirate material from above the larynx, can help protect individuals against COVID-19 pneumonia and, hence, help protect society. We also address critiques presented against widespread adoption of pharyngeal antisepsis.Source
Davidson BL, Tapson VF, Irwin RS, French CL, Elliott CG, Levi M. Pharyngeal Antisepsis to Reduce COVID-19 Pneumonia. Am J Med. 2020 Dec 15:S0002-9343(20)31114-1. doi: 10.1016/j.amjmed.2020.12.001. Epub ahead of print. PMID: 33338507. Link to article on publisher's site
DOI
10.1016/j.amjmed.2020.12.001Permanent Link to this Item
http://hdl.handle.net/20.500.14038/27373PubMed ID
33338507Related Resources
ae974a485f413a2113503eed53cd6c53
10.1016/j.amjmed.2020.12.001